Supernus Pharmaceuticals | SUPN - Interest Income


Supernus Pharmaceuticals reported $2.28M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Abbott USD 77M 6M Sep/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
Cara Therapeutics USD 347K 74K Mar/2025
Corcept Therapeutics USD 5.02M 7K Sep/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Pacira USD 8.53M 3.53M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025